Lorin Gresser

Lorin Gresser is the CEO of Dem Dx, an acclaimed AI healthcare company with a cutting-edge clinical diagnostic platform, crafted in collaboration with over 200 medical experts, to empower frontline healthcare providers with accurate diagnoses and care recommendations.

Under Lorin's leadership, Dem Dx's platform has been proven to be 22% more accurate than Harvard-trained junior doctors, boasts an impressive 85% accuracy rate at initial diagnosis, and accelerates the diagnostic process by reducing time to diagnosis by 40%.

Lorin Gresser holds a Doctor of Medicine (M.D.) degree from Kings College London, a Master of Business Administration (MBA) degree from Harvard Business School, and a Bachelor's Degree in Natural Sciences from the University of Cambridge.

Prior to her role as the CEO of Dem Dx Limited, Lorin held esteemed positions, including Head of Alternative Investments and Product Strategy as well as Director of Strategy at Threadneedle Investments. She also has consulting experience from The Boston Consulting Group.